Amgen

Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Mon, 11/11/13 - 10:35 am
Esperion Therapeutics
ETC-1002
Sanofi
Regeneron
Amgen
Pfizer
Roche
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Roche
Amgen
Gilead
Sanofi
Celgene
Meet the Tiny Biotech Challenging Amgen and General Electric
Motley Fool
Tue, 11/5/13 - 08:08 am
Amgen
Repligen
General Electric
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Fri, 11/1/13 - 08:38 am
patents
Amgen
Neupogen
Merck KGaA
Rebif
Cymbalta
Eli Lilly
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Pfizer
PCSK9 inhibitors
RN-316
Sanofi
Regeneron
REGN727
AMG145
Amgen
This Biotech Trifecta Could Revolutionize Cancer
Motley Fool
Sun, 10/27/13 - 12:53 pm
Intrexon
Ziopharm
Amgen
Osiris Therapeutics
Q3 Earnings Roundup for Pharmaceutical Stocks
InvestorPlace
Fri, 10/25/13 - 11:37 am
earnings
Amgen
Eli Lilly
Bristol-Myers Squibb
Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thu, 10/24/13 - 09:59 am
Celgene
Multiple Myeloma
Amgen
Kyprolis
Pomalyst
Biotech drugmaker Amgen's 3Q profit jumps 24 percent on stronger sales of most of its drugs
Yahoo/AP
Tue, 10/22/13 - 04:56 pm
earnings
Amgen
Amgen acquires Filgrastim franchise rights from Roche
Yahoo/Fly on the Wall
Tue, 10/22/13 - 11:28 am
Roch
filgrastim
Amgen
pegfilgrastim
Whisper Number: What Will Amgen’s Shares Do Post-Earnings?
Wall St. Cheat Sheet
Tue, 10/22/13 - 11:24 am
Amgen
earnings
Can Amgen Grow Faster Than Gilead Sciences and Teva Pharmaceutical?
Motley Fool
Mon, 10/21/13 - 08:37 am
Gilead
Teva
Amgen
3 Things to Watch in Amgen's Earnings Report
Motley Fool
Mon, 10/21/13 - 08:35 am
earnings
Amgen
Earnings Preview: Amgen to report 3Q results
Yahoo/AP
Sat, 10/19/13 - 03:54 pm
earnings
Amgen
Amgen's 3Q report to focus on cancer drugmaker purchase, testing of its own experimental drugs
Yahoo/AP
Fri, 10/18/13 - 09:31 am
Amgen
earnings
Is Amarin's FDA Panel Important for Other Cardiovascular Drugmakers?
Motley Fool
Thu, 10/17/13 - 06:12 pm
FDA
Vascepa
Amarin
AstraZeneca
Regeneron
Amgen
AstraZeneca, Amgen Crohn's drug runs into PhII 'logistical' snafu
Fierce Biotech
Thu, 10/17/13 - 10:57 am
Amgen
Crohn's Disease
AMG 181
AstraZeneca
BIND Therapeutics Had A Muted IPO But The Thesis Intrigues
Seeking Alpha
Wed, 10/9/13 - 10:11 am
Bind Therapeutics
IPOs
AstraZeneca
Amgen
Pfizer
Knockoff Lust: AbbVie's $9 Billion-A-Year Humira
Seeking Alpha
Wed, 10/9/13 - 08:25 am
AbbVie
Humira
JNJ
Amgen
rheumatoid arthritis
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Rexahn
chemotherapy
Amgen
Bristol-Myers Squibb
Merck
Novartis
Teva
RX-3117

Pages